e-learning
resources
Paris 2018
Saturday, 15.09.2018
PG10 Cystic fibrosis: Basic defects and clinical problems in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Newborn screening for cystic fibrosis - lessons from national programmes in Europe
J. Barben (St. Gallen, Switzerland)
Source:
International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children
Session:
PG10 Cystic fibrosis: Basic defects and clinical problems in children
Session type:
Postgraduate Course
Number:
105
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Barben (St. Gallen, Switzerland). Newborn screening for cystic fibrosis - lessons from national programmes in Europe. International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Newborn screening for cystic fibrosis: opportunities and remaining challenges
Source: Eur Respir Monogr 2014; 64: 65-76
Year: 2014
Newborn screening in Europe
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Public awareness on cystic fibrosis: results from a national pragmatic survey
Source: Eur Respir J 2015; 46: 264-267
Year: 2015
Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014
1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes"
Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma
Year: 2010
Need for early intervention in cystic fibrosis - impact of an educational programme
Source: Eur Respir J 2005; 26: Suppl. 49, 621s
Year: 2005
Cystic fibrosis newborn screening programme in central Catalonia area (Spain). What have we learnt 8 years later?
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres
Source: ERJ Open Res, 7 (4) 00249-2021; 10.1183/23120541.00249-2021
Year: 2021
Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Challenges of providing care to adults with cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 286-303
Year: 2014
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
DNA-based screening for CF: which protocol is best in a multiethnic Europe? Lessons from the UK experience
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002
Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice
Source: Eur Respir J 2011; 37: 1175-1182
Year: 2011
Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community?
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Future trends in cystic fibrosis demography in 34 European countries
Source: Eur Respir J 2015; 46: 133-141
Year: 2015
Implementation of supervised physiotherapy in a school environment in children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
The German cystic fibrosis quality assurance project: clinical features in children and adults
Source: Eur Respir J 2001; 17: 1187-1194
Year: 2001
Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs)
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Should the D1152H variant be included in cystic fibrosis newborn screening programmes?
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept